levonorgestrel/ethinyl estradiol

FDA Drug Profile — Twirla

levonorgestrel/ethinyl estradiol is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Twirla. Available dosage form: patch.

Drug details

Generic Name
levonorgestrel/ethinyl estradiol
Brand Names
Twirla
Application Number
NDA204017
Sponsor
Agile Therapeutics, Inc.
NDC Codes
2
Dosage Forms
PATCH
Routes
TRANSDERMAL
Active Ingredients
ETHINYL ESTRADIOL, LEVONORGESTREL

Indications and Usage

1 INDICATIONS AND USAGE TWIRLA is indicated as a method of contraception for use in women of reproductive potential with a BMI < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. Limitation of Use Consider TWIRLA’s reduced effectiveness in women with a BMI ≥ 25 to < 30 kg/m 2 before prescribing TWIRLA [see Use in Specific Populations ( 8.9 ) and Clinical Studies ( 14 )] . TWIRLA is contraindicated in women with a BMI ≥ 30 kg/m 2 [see Contraindications ( 4 )] . TWIRLA is a combination of levonorgestrel, a progestin, and ethinyl estradiol, an estrogen, indicated as a method of contraception for use in women of reproductive potential with a BMI < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. ( 1 ) Limitation of Use Consider TWIRLA’s reduced effectiveness in women with a BMI ≥ 25 to < 30 kg/m 2 before prescribing. ( 4 , 8.9 , 14 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.